טוען...
L‐ornithine L‐aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
BACKGROUND: Hepatic encephalopathy is a common complication of cirrhosis and has high associated morbidity and mortality. The condition is classified as overt if it is clinically apparent or minimal if only evident though psychometric testing. The exact pathogenesis of this syndrome is unknown altho...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2018
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494563/ https://ncbi.nlm.nih.gov/pubmed/29762873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012410.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|